# NULIBRY
> **NDA214018** · New Drug Application · Sponsor: SENTYNL THERAPS INC · Approved 2021-02-26
## Drug
- **FDA Application Number:** NDA214018
- **Application type:** New Drug Application
- **Brand name:** NULIBRY
- **Generic name:** FOSDENOPTERIN HYDROBROMIDE
- **Active ingredients:** FOSDENOPTERIN HYDROBROMIDE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** SENTYNL THERAPS INC
- **Manufacturer:** Sentynl Therapeutics, Inc.
- **First approval:** 2021-02-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214018)
---
*MORVS · CC0 1.0*